Followers | 145 |
Posts | 27566 |
Boards Moderated | 3 |
Alias Born | 02/07/2004 |
Thursday, March 04, 2010 11:23:54 PM
Contact:
David W. Moskowitz MD
CEO, GenoMed
Tel. 314-983-9933
dwmoskowitz@genomed.com
March 4, 2010—GenoMed® (OTC Pink Sheets GMED.PK), the Public Health Company™, announced today that the Securities and Exchange Commission suspended trading in its shares today because the company is delinquent in its SEC filings.
Dr. David Moskowitz, GenoMed's CEO, said, "We are committed to trading on the Pink Sheets again as soon as possible. The problem is money. In the past, auditors and attorneys have charged us on the order of $50,000 a year to file our SEC reports, even though the reports have been quite simple. In September, 2005, we ran out of money to pay auditors and attorneys. I stopped taking a paycheck from GenoMed in May, 2005. For the past few years, I've been supporting the company out of my retirement money. Although I've been working for free since 2005, I haven't found any attorneys or auditors willing to do so."
Dr. Moskowitz continued, "We're trying to bring money into the company just as single-mindedly as before. We're pursuing joint ventures to develop so-called 'kind' chemotherapy: non-toxic pills that slow cancer down. We're also marketing directly to patients with diabetes, high blood pressure, or emphysema."
Dr. Moskowitz ended by saying, "I remain committed to all the company's investors. I am one myself. Becoming compliant with the SEC again should have the effect of an IPO, with a resultant increase in our share price. Most importantly, I believe in our mission to transform healthcare: to save lives while lowering costs. I continue to believe that it's only a matter of time before word leaks out, especially to Baby Boomers, that we can prevent 90% of kidney failure and save Medicare 10% of its budget. It's not our fault that Medicare doesn't want to."
About GenoMed (www.genomed.com)
GenoMed was founded in 2001 by Dr. David Moskowitz, a kidney specialist. The company recently began a "Dialysis-Free in 5" campaign: it will gladly work with any community in the world that wants to eliminate 90% of dialysis within 5 years. GenoMed hopes to make the St. Louis area dialysis-free by 2015.
Recent GMED News
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 05/10/2024 08:48:50 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 05/10/2024 08:15:52 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 05/10/2024 04:11:54 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 05/08/2024 08:11:33 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 05/08/2024 07:59:27 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/07/2024 08:21:08 PM
- Globus Medical Reports First Quarter 2024 Results • GlobeNewswire Inc. • 05/07/2024 08:15:00 PM
- Globus Medical Schedules First Quarter Earnings Release and Conference Call • GlobeNewswire Inc. • 04/16/2024 08:30:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/05/2024 10:07:51 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 03/01/2024 11:50:16 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/20/2024 09:35:42 PM
- Globus Medical Reports Fourth Quarter and Full Year 2023 Results • GlobeNewswire Inc. • 02/20/2024 09:15:00 PM
- Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] • Edgar (US Regulatory) • 02/14/2024 09:08:54 PM
- Globus Medical Schedules Fourth Quarter and Full Year 2023 Earnings Release and Conference Call • GlobeNewswire Inc. • 02/13/2024 10:17:08 PM
- Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] • Edgar (US Regulatory) • 02/13/2024 06:08:02 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/05/2024 09:45:09 PM
- Globus Medical promotes Keith Pfeil to Chief Operating Officer and Chief Financial Officer • GlobeNewswire Inc. • 02/05/2024 09:30:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/30/2024 10:11:40 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/30/2024 10:09:55 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/30/2024 10:06:20 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/30/2024 09:58:48 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/30/2024 09:55:53 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/30/2024 09:50:33 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/30/2024 09:46:32 PM
Avant Technologies Equipping AI-Managed Data Center with High Performance Computing Systems • AVAI • May 10, 2024 8:00 AM
VAYK Discloses Strategic Conversation on Potential Acquisition of $4 Million Home Service Business • VAYK • May 9, 2024 9:00 AM
Bantec's Howco Awarded $4.19 Million Dollar U.S. Department of Defense Contract • BANT • May 8, 2024 10:00 AM
Element79 Gold Corp Successfully Closes Maverick Springs Option Agreement • ELEM • May 8, 2024 9:05 AM
Kona Gold Beverages, Inc. Achieves April Revenues Exceeding $586,000 • KGKG • May 8, 2024 8:30 AM
Epazz plans to spin off Galaxy Batteries Inc. • EPAZ • May 8, 2024 7:05 AM